A Systematic Review of Cognitive and Behavioral Treatments for Individuals with Psoriasis.

Conclusion: CBT as an adjunct to conventional dermatological treatments may be particularly beneficial for individuals with more severe pretreatment psychopathology in improving psoriasis severity, anxiety, and depression symptoms. CBT appears to be generally effective in improving quality of life. Greater methodological rigour is needed in future research. PMID: 31696748 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research

Related Links:

This study attempts to do so by examining individual differences in psoriasis patients ’ wellbeing, anxiety and depression using a clinically modified Buddhist psychological model (CBPM). Psoriasis patients (N = 285) and (N = 209) completed measures of each CBPM component at time 1 and 2. SEM analyses found that a direct and mediated effect of CBPM model was a good fit to the participant’s data. This study suggests that non-attachment, aversion, acceptance and self-compassion could have a direct effect on the we llbeing, anxiety and depression of psoriasis patients and an indirect ef...
Source: Journal of Clinical Psychology in Medical Settings - Category: Psychiatry & Psychology Source Type: research
ConclusionThis study provides some initial evidence on what the mechanisms of mindfulness might be.
Source: Mindfulness - Category: Psychiatry & Psychology Source Type: research
We examined rates of depression screening among in psoriasis and AD in United States outpatients. PMID: 31648383 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Tags: Br J Dermatol Source Type: research
AbstractPsoriasis is a prevalent skin disease that impairs multiple domains of quality of life (QoL). Pruritus, a common symptom in patients with psoriasis, may directly affect sleep, but studies investigating this are limited. We investigated the relationships between pruritus and sleep in 104 in-patients with psoriasis, who underwent dermatological assessment and completed questionnaires to determine psoriasis severity, pruritus intensity, sleep quality, QoL (skin disease-specific and generic), depressive mood and anxiety. In total, 80% of patients reported pruritus, and 39% had sleep disturbances, most commonly awakenin...
Source: Archives of Dermatological Research - Category: Dermatology Source Type: research
ConclusionsThe results suggest that MBCT may be a useful adjunct therapy for those suffering from psoriasis and the associated psychological symptoms relating to the condition.
Source: Mindfulness - Category: Psychiatry & Psychology Source Type: research
The association between psoriasis and risk of psychiatric disorders has not been thoroughly evaluated in a large longitudinal cohort of Asian population. We conducted a nationwide population-based retrospective cohort study encompassing more than 1.6 million Koreans with a 12-year follow-up period. Patients were considered in the psoriasis cohort if they had an incident diagnostic code for psoriasis and included patients were followed up until they developed any psychiatric disease. In adjusted models, psoriasis patients (n = 10,868) were at a 18% increased risk for depression (hazard ratio [HR] 1.18, 95% confidence interv...
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: Tags: Clinical Research and Epidemiology Source Type: research
Introduction: Anxiety and depression are comorbidities associated with psoriasis. The total healthcare cost reduction associated with improvements in anxiety and depression in psoriasis patients derived from newer biologic treatments is unknown.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research
Psoriasis is a chronic, systemic, inflammatory disease involving skin, nails, and joints. Nail psoriasis may lead to many difficulties in daily activities including work and impairment in quality of life and may also be the cause of severe pain, anxiety and depression. A 66-year-old woman with a history of seronegative arthritis receiving methotrexate presented with severe ungual dystrophy affecting all 20 nails. Clinical examination revealed subungual hyperkeratosis, salmon patches, periungual erythema, onycholysis and nail crumbling.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research
Authors: Reich K, Foley P, Han C, McElligott S, Muser E, Li N, Armstrong AW Abstract Purpose: To evaluate the impact of guselkumab on work productivity, including absenteeism and presenteeism, in psoriasis patients with and without depression/anxiety. Methods: VOYAGE 2 is a randomized, double-blind, placebo-controlled, and comparator-controlled, phase 3 trial that compared guselkumab with adalimumab in patients with moderate-to-severe psoriasis. Absenteeism was evaluated among patients who reported that their skin prevented work/study based on the Dermatology Life Quality Index (DLQI) work/study domain (score = 3) ...
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
Authors: Cai Q, Teeple A, Wu B, Muser E Abstract Objective: To describe the prevalence and costs of anxiety and depression among moderate-to-severe psoriasis (PsO) patients in a commercially-insured US population. Methods: The IBM® MarketScan® Commercial database was used to select adults with moderate-to-severe PsO (≥1 PsO diagnosis and ≥1 systemic or biologic medication) within each calendar year from 2014-2016. Adults with no diagnosis of PsO or similar disorders were randomly selected (2014-2016) and matched 1:1 to PsO patients to compare the prevalence of anxiety and depression each year. Moderat...
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
More News: Anxiety | Databases & Libraries | Depression | Dermatology | Psoriasis | Psychology | Psychotherapy | Skin | Study